← Back to guidelines
Oncology5 papers

Bronchial anastomotic necrosis

Last edited: 4/10/2026

Overview

Vesico-urethral anastomotic stenosis (VUAS) is a potential complication following prostatectomy 1. Endoscopic procedures are frequently utilized as the initial management strategy for this condition, although their definitive success rates have historically remained unclear 1.

Management

  • Endoscopic Procedures: Endoscopic treatment for VUAS has a pooled success rate of 72.8% (95% CI 64.4%–79.9%) 1.
  • Adjusted Success Rates: When accounting for potential publication bias using trim-and-fill analysis, the corrected overall success rate is estimated at 62.9% (95% CI 53.6%–71.4%) 1.
  • Special Populations

  • History of Radiotherapy: Prior radiotherapy is a significant negative predictor of success for endoscopic management of anastomotic stenosis (P = 0.012) 1.
  • Key Recommendations

  • Endoscopic procedures should be considered a viable initial treatment option for vesico-urethral anastomotic stenosis following prostatectomy, with an expected success rate of approximately 63% to 73% 1. (Evidence: Strong)
  • Clinicians should identify a history of radiotherapy as a factor that significantly reduces the likelihood of successful endoscopic treatment for anastomotic stenosis 1. (Evidence: Strong)
  • References

    1 Delchet O, Nourredine M, González Serrano A, Morel-Journel N, Carnicelli D, Ruffion A et al.. Post-prostatectomy anastomotic stenosis: systematic review and meta-analysis of endoscopic treatment. BJU international 2024. link

    Original source

    1. [1]
      Post-prostatectomy anastomotic stenosis: systematic review and meta-analysis of endoscopic treatment.Delchet O, Nourredine M, González Serrano A, Morel-Journel N, Carnicelli D, Ruffion A et al. BJU international (2024)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG